Skip to main content
Premium Trial:

Request an Annual Quote

Euformatics Wins €350K European Grant to Develop NGS Workflows for Cancer, Rare Disease Dx

NEW YORK – Euformatics said Thursday that it has received a €350,000 ($363,000) grant from the European Commission's Recovery and Resilience Facility to create new software algorithms and workflows for diagnosing cancer and rare diseases from next-generation sequencing data. The Finnish company will also use some of the money to develop a quality control system that will allow groups of NGS labs to compare and validate their pipelines together.

A company spokesperson said that the two-year grant will cover half of the total project cost of €700,000.

The €723.8 billion Recovery and Resistance Facility is meant to help European Union countries recover from the COVID-19 pandemic. Healthcare and digital transformation are among the areas the fund is assisting.

"This research funding enables us to plan our development roadmap and offering in the long term so that the products will be based on a solid scientific foundation," Euformatics CEO Tommi Kaasalainen said in a statement. "We look forward to working with both industry and academic partners to showcase the results during the next several years."

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.